Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 10Gynecologic 2Classical hematology 2Sarcoma 1Head & Neck 1CNS 1Breast 1

Conditions

Thyroid Diseases 2Thyroid Nodule 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Hyperthyroidism 1Goiter 1Desmoid Tumors 1

Interventions

pembrolizumab 33Cetuximab 16Cisplatin 10Radiotherapy 8Paclitaxel 8Docetaxel 8atezolizumab 7Fluorouracil 7cemiplimab 6Drug Therapy 6budigalimab 5Gemcitabine 5Cyclophosphamide 5Blood Specimen Collection 5trametinib 4Pemetrexed 4Nivolumab 4Magnetic Resonance Spectroscopy 4Bleomycin 4Bevacizumab 4palbociclib 3fludarabine 3durvalumab 3dabrafenib 3avelumab 3Trastuzumab 3Oxaliplatin 3Interleukin-2 3Indocyanine Green 3Immunotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Data Collection × Head & Neck × Clear all
NCT02651246 2021-06-24

Optional Sub-study to Intraoperative Imaging With ICG Registry

Abramson Cancer Center at Penn Medicine

Completed
291 enrolled
Head & NeckSarcoma

Neoplasms, Thyroid Diseases, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡